Tscan Therapeutics Inc’s recently made public that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $1.67 million on May 19 ’25. In the deal valued at $1.20 per share,1,388,794 shares were bought. As a result of this transaction, Lynx1 Capital Management LP now holds 6,746,141 shares worth roughly $7.42 million.
Then, Lynx1 Capital Management LP bought 1,200,000 shares, generating $1,440,000 in total proceeds. Upon buying the shares at $1.20, the 10% Owner now owns 7,946,141 shares.
Before that, Lynx1 Capital Management LP bought 100,000 shares. Tscan Therapeutics Inc shares valued at $290,140 were divested by the 10% Owner at a price of $2.90 per share. As a result of the transaction, Lynx1 Capital Management LP now holds 5,357,347 shares, worth roughly $5.89 million.
Morgan Stanley downgraded its Tscan Therapeutics Inc [TCRX] rating to an Equal-weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in mid May with a ‘”a Buy”‘ rating. Needham began covering TCRX with “Buy” recommendation on May 13, 2024. Wedbush started covering the stock on June 22, 2023. It rated TCRX as “an Outperform”.
Price Performance Review of TCRX
On Friday, Tscan Therapeutics Inc [NASDAQ:TCRX] saw its stock fall -2.65% to $1.1. Over the last five days, the stock has gained 0.92%. Tscan Therapeutics Inc shares have fallen nearly -79.70% since the year began. Nevertheless, the stocks have fallen -63.82% over the past one year. While a 52-week high of $5.30 was reached on 01/03/25, a 52-week low of $1.02 was recorded on 11/10/25.
Levels Of Support And Resistance For TCRX Stock
The 24-hour chart illustrates a support level at 1.0733, which if violated will result in even more drops to 1.0467. On the upside, there is a resistance level at 1.1383. A further resistance level may holdings at 1.1767.
How much short interest is there in Tscan Therapeutics Inc?
A steep rise in short interest was recorded in Tscan Therapeutics Inc stocks on 2025-10-31, growing by 0.17 million shares to a total of 1.74 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 1.57 million shares. There was a rise of 10.01%, which implies that there is a positive sentiment for the stock.
